Wang Wei, Sai Wen-Li, Yang Bin
Nantong-Leicester Joint Institute of Kidney Science, Department of Nephrology, Affiliated Hospital of Nantong University, Nantong 226001, China.
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
Sheng Li Xue Bao. 2022 Feb 25;74(1):28-38.
Acute kidney injury (AKI) is a common critical clinical disease characterized by a sharp decline of renal function. Ischemia-reperfusion (IR) is one of the main causes of AKI. The mortality of AKI remains high due to the lack of early diagnosis and cause specific treatment. IR rapidly initiates innate immune responses, activates complement and innate immune cells, releasing a large number of injury-related molecules such as high mobility group box-1 (HMGB1), inflammatory mediators such as caspase-3, and then recruits immune inflammatory cells including M1 macrophages (Mϕ) to the microenvironment of injury, causing apoptosis and necrosis of renal tubular epithelial cells (TECs). Dead cells and associated inflammation further activate the adaptive immune system, which not only aggravates tissue damage, but also initiates M2 Mϕ participated inflammatory clearance, tissue repair and regeneration. Mϕ, professional phagocytes, and TECs, semi-professional phagocytes, can phagocytose around damaged cells including apoptotic Mϕ and TECs, which are key innate immune cells to regulate the outcome of injury, repair or fibrosis. In recent years, it has been found that erythropoietin (EPO) not only binds to the homodimeric receptor (EPOR) to induce erythropoiesis, but also binds to the heterodimeric receptor EPOR/βcR, also known as innate repair receptor, which plays renoprotective roles. Properdin is the only positive regulator in the complement activation of alternative pathway. It also can effectively identify and bind to early apoptotic T cells and facilitate phagocytic clearing by Mϕ through a non-complement activation-dependent mechanism. Our previous studies have shown that Mϕ and TECs associated with EPO and its receptors and properdin are involved in IR injury and repair, but the underlying mechanism needs to be further explored. As an important carrier of cell-to-cell signal transmission, exosomes participate in the occurrence and development of a variety of renal diseases. The role of exosomes involved in the interaction between Mϕ and TECs in IR-induced AKI is not fully defined. Based on the available results in the role of Mϕ and TECs in renal IR-induced AKI, this review discussed the role of Mϕ polarization and interaction with TECs in renal IR injury, as well as the participation of EPO and its receptors, properdin and exosomes.
急性肾损伤(AKI)是一种常见的严重临床疾病,其特征是肾功能急剧下降。缺血再灌注(IR)是AKI的主要病因之一。由于缺乏早期诊断和针对性治疗,AKI的死亡率仍然很高。IR迅速引发先天性免疫反应,激活补体和先天性免疫细胞,释放大量与损伤相关的分子,如高迁移率族蛋白B1(HMGB1)、炎症介质如半胱天冬酶-3,然后招募包括M1巨噬细胞(Mϕ)在内的免疫炎症细胞至损伤微环境,导致肾小管上皮细胞(TECs)凋亡和坏死。死亡细胞及相关炎症进一步激活适应性免疫系统,这不仅会加重组织损伤,还会启动M2 Mϕ参与的炎症清除、组织修复和再生。Mϕ作为专业吞噬细胞,TECs作为半专业吞噬细胞,能够吞噬周围受损细胞,包括凋亡的Mϕ和TECs,它们是调节损伤、修复或纤维化结局的关键先天性免疫细胞。近年来发现,促红细胞生成素(EPO)不仅与同二聚体受体(EPOR)结合以诱导红细胞生成,还与异二聚体受体EPOR/βcR结合,后者也被称为先天性修复受体,具有肾脏保护作用。备解素是替代途径补体激活中的唯一正向调节因子。它还能有效识别并结合早期凋亡T细胞,并通过非补体激活依赖性机制促进Mϕ的吞噬清除。我们之前的研究表明,与EPO及其受体和备解素相关的Mϕ和TECs参与IR损伤和修复,但其潜在机制仍需进一步探索。作为细胞间信号传递的重要载体,外泌体参与多种肾脏疾病的发生和发展。外泌体在IR诱导的AKI中参与Mϕ与TECs相互作用的作用尚未完全明确。基于Mϕ和TECs在肾脏IR诱导的AKI中的作用的现有结果,本综述讨论了Mϕ极化及其与TECs在肾脏IR损伤中的相互作用,以及EPO及其受体、备解素和外泌体的参与情况。